25 XP   0   0   10

Orthocell Ltd
Buy, Hold or Sell?

Let's analyse Orthocell together

PenkeI guess you are interested in Orthocell Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Orthocell Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Orthocell Ltd

I send you an email if I find something interesting about Orthocell Ltd.

Quick analysis of Orthocell (30 sec.)










What can you expect buying and holding a share of Orthocell? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$-0.04
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.07
Return On Investment
-19.7%

For what price can you sell your share?

Current Price per Share
A$0.37
Expected price per share
A$0.32 - A$0.4
How sure are you?
50%

1. Valuation of Orthocell (5 min.)




Live pricePrice per Share (EOD)

A$0.37

Intrinsic Value Per Share

A$0.05 - A$0.84

Total Value Per Share

A$0.08 - A$0.87

2. Growth of Orthocell (5 min.)




Is Orthocell growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9m$6.3m-$2.4m-61.1%

How much money is Orthocell making?

Current yearPrevious yearGrowGrow %
Making money-$4m-$5.8m$1.8m45.7%
Net Profit Margin-147.3%-594.5%--

How much money comes from the company's main activities?

3. Financial Health of Orthocell (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#782 / 1019

Most Revenue
#415 / 1019

Most Profit
#389 / 1019

Most Efficient
#611 / 1019

What can you expect buying and holding a share of Orthocell? (5 min.)

Welcome investor! Orthocell's management wants to use your money to grow the business. In return you get a share of Orthocell.

What can you expect buying and holding a share of Orthocell?

First you should know what it really means to hold a share of Orthocell. And how you can make/lose money.

Speculation

The Price per Share of Orthocell is A$0.365. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Orthocell.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Orthocell, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Orthocell.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-5.2%-0.02-5.2%-0.03-7.6%-0.02-6.1%-0.02-4.7%
Usd Book Value Change Per Share-0.01-3.1%-0.01-3.1%-0.02-5.8%0.000.6%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-3.1%-0.01-3.1%-0.02-5.8%0.000.6%0.000.5%
Usd Price Per Share0.22-0.22-0.26-0.28-0.22-
Price to Earnings Ratio-11.73--11.73--9.31--12.73--12.73-
Price-to-Total Gains Ratio-19.51--19.51--12.16--8.61--45.26-
Price to Book Ratio11.91-11.91-8.56-8.18-11.28-
Price-to-Total Gains Ratio-19.51--19.51--12.16--8.61--45.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.233746
Number of shares4278
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (4278 shares)-49.159.89
Gains per Year (4278 shares)-196.6139.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-197-20704030
20-393-40407970
30-590-6010119110
40-786-7980158150
50-983-9950198190
60-1180-11920237230
70-1376-13890277270
80-1573-15860316310
90-1770-17830356350
100-1966-19800395390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.03.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%6.07.00.046.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%6.07.00.046.2%

Fundamentals of Orthocell

About Orthocell Ltd

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Fundamental data was last updated by Penke on 2024-04-09 02:07:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Orthocell Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Orthocell earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • A Net Profit Margin of -147.3% means that $-1.47 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Orthocell Ltd:

  • The MRQ is -147.3%. The company is making a huge loss. -2
  • The TTM is -147.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-147.3%TTM-147.3%0.0%
TTM-147.3%YOY-594.5%+447.3%
TTM-147.3%5Y-604.5%+457.3%
5Y-604.5%10Y-609.8%+5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-147.3%-197.2%+49.9%
TTM-147.3%-210.4%+63.1%
YOY-594.5%-279.3%-315.2%
5Y-604.5%-436.8%-167.7%
10Y-609.8%-599.3%-10.5%
1.1.2. Return on Assets

Shows how efficient Orthocell is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • -21.1% Return on Assets means that Orthocell generated $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Orthocell Ltd:

  • The MRQ is -21.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.1%TTM-21.1%0.0%
TTM-21.1%YOY-24.0%+2.9%
TTM-21.1%5Y-32.3%+11.2%
5Y-32.3%10Y-46.3%+14.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.1%-13.6%-7.5%
TTM-21.1%-12.9%-8.2%
YOY-24.0%-11.9%-12.1%
5Y-32.3%-14.2%-18.1%
10Y-46.3%-16.2%-30.1%
1.1.3. Return on Equity

Shows how efficient Orthocell is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • -101.6% Return on Equity means Orthocell generated $-1.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Orthocell Ltd:

  • The MRQ is -101.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -101.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-101.6%TTM-101.6%0.0%
TTM-101.6%YOY-91.9%-9.7%
TTM-101.6%5Y-66.2%-35.4%
5Y-66.2%10Y-85.3%+19.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.6%-17.0%-84.6%
TTM-101.6%-16.1%-85.5%
YOY-91.9%-15.4%-76.5%
5Y-66.2%-20.0%-46.2%
10Y-85.3%-21.1%-64.2%

1.2. Operating Efficiency of Orthocell Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Orthocell is operating .

  • Measures how much profit Orthocell makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • An Operating Margin of -243.0% means the company generated $-2.43  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Orthocell Ltd:

  • The MRQ is -243.0%. The company is operating very inefficient. -2
  • The TTM is -243.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-243.0%TTM-243.0%0.0%
TTM-243.0%YOY-752.4%+509.4%
TTM-243.0%5Y-852.5%+609.5%
5Y-852.5%10Y-861.0%+8.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-243.0%-286.1%+43.1%
TTM-243.0%-224.4%-18.6%
YOY-752.4%-288.4%-464.0%
5Y-852.5%-475.2%-377.3%
10Y-861.0%-624.7%-236.3%
1.2.2. Operating Ratio

Measures how efficient Orthocell is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.43 means that the operating costs are $3.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Orthocell Ltd:

  • The MRQ is 3.430. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.430. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.430TTM3.4300.000
TTM3.430YOY8.524-5.094
TTM3.4305Y9.525-6.095
5Y9.52510Y10.005-0.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4302.997+0.433
TTM3.4303.247+0.183
YOY8.5243.766+4.758
5Y9.5255.675+3.850
10Y10.0057.857+2.148

1.3. Liquidity of Orthocell Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Orthocell is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.93 means the company has $5.93 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Orthocell Ltd:

  • The MRQ is 5.930. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.930. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.930TTM5.9300.000
TTM5.930YOY5.172+0.758
TTM5.9305Y7.025-1.095
5Y7.02510Y5.684+1.341
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9303.930+2.000
TTM5.9304.251+1.679
YOY5.1725.436-0.264
5Y7.0256.045+0.980
10Y5.6846.363-0.679
1.3.2. Quick Ratio

Measures if Orthocell is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • A Quick Ratio of 5.66 means the company can pay off $5.66 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Orthocell Ltd:

  • The MRQ is 5.664. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.664. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.664TTM5.6640.000
TTM5.664YOY5.070+0.594
TTM5.6645Y6.883-1.219
5Y6.88310Y5.549+1.334
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6643.629+2.035
TTM5.6644.065+1.599
YOY5.0705.397-0.327
5Y6.8835.993+0.890
10Y5.5496.277-0.728

1.4. Solvency of Orthocell Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Orthocell assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Orthocell to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.79 means that Orthocell assets are financed with 79.2% credit (debt) and the remaining percentage (100% - 79.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Orthocell Ltd:

  • The MRQ is 0.792. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.792. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.792TTM0.7920.000
TTM0.792YOY0.739+0.054
TTM0.7925Y0.393+0.399
5Y0.39310Y0.367+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7920.332+0.460
TTM0.7920.334+0.458
YOY0.7390.268+0.471
5Y0.3930.366+0.027
10Y0.3670.390-0.023
1.4.2. Debt to Equity Ratio

Measures if Orthocell is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Orthocell to the Biotechnology industry mean.
  • A Debt to Equity ratio of 381.5% means that company has $3.81 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Orthocell Ltd:

  • The MRQ is 3.815. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.815. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.815TTM3.8150.000
TTM3.815YOY2.826+0.989
TTM3.8155Y1.433+2.382
5Y1.43310Y1.004+0.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8150.381+3.434
TTM3.8150.390+3.425
YOY2.8260.334+2.492
5Y1.4330.434+0.999
10Y1.0040.466+0.538

2. Market Valuation of Orthocell Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Orthocell generates.

  • Above 15 is considered overpriced but always compare Orthocell to the Biotechnology industry mean.
  • A PE ratio of -11.73 means the investor is paying $-11.73 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Orthocell Ltd:

  • The EOD is -12.228. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.726. Based on the earnings, the company is expensive. -2
  • The TTM is -11.726. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.228MRQ-11.726-0.503
MRQ-11.726TTM-11.7260.000
TTM-11.726YOY-9.309-2.416
TTM-11.7265Y-12.733+1.007
5Y-12.73310Y-12.727-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.228-2.315-9.913
MRQ-11.726-2.560-9.166
TTM-11.726-2.664-9.062
YOY-9.309-4.122-5.187
5Y-12.733-6.258-6.475
10Y-12.727-6.108-6.619
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Orthocell Ltd:

  • The EOD is 5.473. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.248. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.248. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.473MRQ5.248+0.225
MRQ5.248TTM5.2480.000
TTM5.248YOY-12.474+17.722
TTM5.2485Y-66.954+72.202
5Y-66.95410Y-40.568-26.386
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.473-3.067+8.540
MRQ5.248-3.251+8.499
TTM5.248-3.545+8.793
YOY-12.474-5.595-6.879
5Y-66.954-8.315-58.639
10Y-40.568-8.708-31.860
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Orthocell is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.91 means the investor is paying $11.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Orthocell Ltd:

  • The EOD is 12.426. Based on the equity, the company is expensive. -2
  • The MRQ is 11.915. Based on the equity, the company is expensive. -2
  • The TTM is 11.915. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.426MRQ11.915+0.511
MRQ11.915TTM11.9150.000
TTM11.915YOY8.559+3.356
TTM11.9155Y8.180+3.735
5Y8.18010Y11.284-3.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.4261.905+10.521
MRQ11.9152.111+9.804
TTM11.9152.095+9.820
YOY8.5592.836+5.723
5Y8.1803.443+4.737
10Y11.2843.794+7.490
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Orthocell Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Orthocell Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.018-0.0180%-0.033+86%0.004-597%0.003-733%
Book Value Per Share--0.0290.0290%0.047-38%0.062-52%0.042-31%
Current Ratio--5.9305.9300%5.172+15%7.025-16%5.684+4%
Debt To Asset Ratio--0.7920.7920%0.739+7%0.393+101%0.367+116%
Debt To Equity Ratio--3.8153.8150%2.826+35%1.433+166%1.004+280%
Dividend Per Share----0%-0%-0%-0%
Eps---0.030-0.0300%-0.044+46%-0.035+16%-0.027-10%
Free Cash Flow Per Share--0.0670.0670%-0.032+149%-0.003+105%-0.010+115%
Free Cash Flow To Equity Per Share--0.0660.0660%-0.025+138%0.025+164%0.014+386%
Gross Profit Margin--1.2741.2740%1.362-7%1.250+2%1.197+6%
Intrinsic Value_10Y_max--0.845--------
Intrinsic Value_10Y_min--0.050--------
Intrinsic Value_1Y_max--0.021--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.112--------
Intrinsic Value_3Y_min--0.002--------
Intrinsic Value_5Y_max--0.261--------
Intrinsic Value_5Y_min--0.011--------
Market Cap76404357.920+4%73264452.80073264452.8000%84777438.240-14%90847921.472-19%72427144.768+1%
Net Profit Margin---1.473-1.4730%-5.945+304%-6.045+311%-6.098+314%
Operating Margin---2.430-2.4300%-7.524+210%-8.525+251%-8.610+254%
Operating Ratio--3.4303.4300%8.524-60%9.525-64%10.005-66%
Pb Ratio12.426+4%11.91511.9150%8.559+39%8.180+46%11.284+6%
Pe Ratio-12.228-4%-11.726-11.7260%-9.309-21%-12.733+9%-12.727+9%
Price Per Share0.365+4%0.3500.3500%0.405-14%0.434-19%0.346+1%
Price To Free Cash Flow Ratio5.473+4%5.2485.2480%-12.474+338%-66.954+1376%-40.568+873%
Price To Total Gains Ratio-20.344-4%-19.508-19.5080%-12.164-38%-8.613-56%-45.261+132%
Quick Ratio--5.6645.6640%5.070+12%6.883-18%5.549+2%
Return On Assets---0.211-0.2110%-0.240+14%-0.323+53%-0.463+119%
Return On Equity---1.016-1.0160%-0.919-10%-0.662-35%-0.853-16%
Total Gains Per Share---0.018-0.0180%-0.033+86%0.004-597%0.003-733%
Usd Book Value--3937789.5013937789.5010%6342927.614-38%8268318.007-52%5687589.707-31%
Usd Book Value Change Per Share---0.011-0.0110%-0.021+86%0.002-597%0.002-733%
Usd Book Value Per Share--0.0190.0190%0.030-38%0.039-52%0.027-31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.019-0.0190%-0.028+46%-0.022+16%-0.017-10%
Usd Free Cash Flow--8940635.2878940635.2870%-4352465.792+149%-427546.538+105%-1347236.889+115%
Usd Free Cash Flow Per Share--0.0430.0430%-0.021+149%-0.002+105%-0.006+115%
Usd Free Cash Flow To Equity Per Share--0.0420.0420%-0.016+138%0.016+164%0.009+386%
Usd Market Cap48929350.812+4%46918555.57346918555.5730%54291471.449-14%58179008.911-19%46382343.509+1%
Usd Price Per Share0.234+4%0.2240.2240%0.259-14%0.278-19%0.222+1%
Usd Profit---4001335.112-4001335.1120%-5831857.034+46%-4661475.955+16%-3588758.565-10%
Usd Revenue--2717261.3882717261.3880%980912.207+177%1101439.970+147%761881.062+257%
Usd Total Gains Per Share---0.011-0.0110%-0.021+86%0.002-597%0.002-733%
 EOD+4 -4MRQTTM+0 -0YOY+21 -135Y+15 -1910Y+17 -17

4.2. Fundamental Score

Let's check the fundamental score of Orthocell Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.228
Price to Book Ratio (EOD)Between0-112.426
Net Profit Margin (MRQ)Greater than0-1.473
Operating Margin (MRQ)Greater than0-2.430
Quick Ratio (MRQ)Greater than15.664
Current Ratio (MRQ)Greater than15.930
Debt to Asset Ratio (MRQ)Less than10.792
Debt to Equity Ratio (MRQ)Less than13.815
Return on Equity (MRQ)Greater than0.15-1.016
Return on Assets (MRQ)Greater than0.05-0.211
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Orthocell Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.540
Ma 20Greater thanMa 500.388
Ma 50Greater thanMa 1000.397
Ma 100Greater thanMa 2000.398
OpenGreater thanClose0.380
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets29,605
Total Liabilities23,457
Total Stockholder Equity6,149
 As reported
Total Liabilities 23,457
Total Stockholder Equity+ 6,149
Total Assets = 29,605

Assets

Total Assets29,605
Total Current Assets26,866
Long-term Assets2,739
Total Current Assets
Cash And Cash Equivalents 24,818
Net Receivables 843
Inventory 1,034
Other Current Assets 171
Total Current Assets  (as reported)26,866
Total Current Assets  (calculated)26,866
+/-0
Long-term Assets
Property Plant Equipment 1,606
Intangible Assets 1,133
Other Assets 0
Long-term Assets  (as reported)2,739
Long-term Assets  (calculated)2,739
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities4,530
Long-term Liabilities18,926
Total Stockholder Equity6,149
Total Current Liabilities
Short-term Debt 181
Accounts payable 876
Other Current Liabilities 1,170
Total Current Liabilities  (as reported)4,530
Total Current Liabilities  (calculated)2,226
+/- 2,304
Long-term Liabilities
Long term Debt Total 382
Other Liabilities 18,545
Long-term Liabilities  (as reported)18,926
Long-term Liabilities  (calculated)18,926
+/- 0
Total Stockholder Equity
Common Stock57,898
Retained Earnings -59,084
Accumulated Other Comprehensive Income 7,335
Total Stockholder Equity (as reported)6,149
Total Stockholder Equity (calculated)6,149
+/-0
Other
Capital Stock57,898
Cash And Equivalents24,818
Cash and Short Term Investments 24,818
Common Stock Shares Outstanding 197,213
Current Deferred Revenue2,304
Liabilities and Stockholders Equity 29,605
Net Debt -24,256
Net Invested Capital 6,149
Net Tangible Assets 5,016
Net Working Capital 22,336
Property Plant and Equipment Gross 2,933
Short Long Term Debt Total 562



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302011-06-302010-06-30
> Total Assets 
1,517
1,909
1,765
9,571
6,536
7,113
7,159
5,230
13,598
23,171
19,330
37,896
29,605
29,60537,89619,33023,17113,5985,2307,1597,1136,5369,5711,7651,9091,517
   > Total Current Assets 
0
0
0
8,518
5,185
5,560
5,285
3,229
11,528
20,805
17,072
35,264
26,866
26,86635,26417,07220,80511,5283,2295,2855,5605,1858,518000
       Cash And Cash Equivalents 
212
559
591
8,185
4,774
5,182
5,046
2,910
11,236
20,442
16,329
11,022
24,818
24,81811,02216,32920,44211,2362,9105,0465,1824,7748,185591559212
       Net Receivables 
613
563
149
156
178
185
117
170
196
253
264
23,547
843
84323,547264253196170117185178156149563613
       Other Current Assets 
11
10
0
305
82
59
34
95
41
63
11
82
171
171821163419534598230501011
   > Long-term Assets 
0
0
0
1,053
1,351
1,553
1,874
2,001
2,070
2,365
2,258
2,632
2,739
2,7392,6322,2582,3652,0702,0011,8741,5531,3511,053000
       Property Plant Equipment 
376
348
303
288
306
289
358
341
287
736
934
1,402
1,606
1,6061,402934736287341358289306288303348376
       Intangible Assets 
197
281
538
765
1,045
1,264
1,516
1,660
1,782
1,630
1,324
1,230
1,133
1,1331,2301,3241,6301,7821,6601,5161,2641,045765538281197
       Long-term Assets Other 
0
0
0
0
0
1,553
1,874
2,001
2,070
-2,365
-2,258
-2,632
-2,739
-2,739-2,632-2,258-2,3652,0702,0011,8741,55300000
> Total Liabilities 
205
343
1,551
1,667
2,152
2,229
2,446
2,858
2,873
2,267
2,456
27,991
23,457
23,45727,9912,4562,2672,8732,8582,4462,2292,1521,6671,551343205
   > Total Current Liabilities 
205
343
687
857
1,302
1,520
1,880
2,433
2,873
1,861
1,934
6,818
4,530
4,5306,8181,9341,8612,8732,4331,8801,5201,302857687343205
       Short-term Debt 
0
0
0
0
0
0
0
0
108
108
114
120
181
18112011410810800000000
       Accounts payable 
101
145
278
711
629
649
891
1,020
1,649
790
893
3,282
876
8763,2828937901,6491,020891649629711278145101
       Other Current Liabilities 
104
198
409
341
531
730
847
1,271
1,224
963
927
1,111
1,170
1,1701,1119279631,2241,271847730531341409198104
   > Long-term Liabilities 
0
0
0
810
850
709
567
425
406
406
522
21,173
18,926
18,92621,173522406406425567709850810000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
393
508
388
382
382388508393000000000
       Other Liabilities 
0
0
864
756
850
709
567
425
14
13
15
20,786
18,545
18,54520,78615131442556770985075686400
> Total Stockholder Equity
1,312
1,566
214
7,904
4,384
4,885
4,712
2,372
10,724
20,903
16,874
9,905
6,149
6,1499,90516,87420,90310,7242,3724,7124,8854,3847,9042141,5661,312
   Common Stock
1,914
3,090
3,163
15,251
15,302
19,360
23,103
25,985
39,027
53,675
55,776
57,476
57,898
57,89857,47655,77653,67539,02725,98523,10319,36015,30215,2513,1633,0901,914
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 
0
0
0
1,078
798
1,027
1,289
1,026
1,955
3,376
6,213
5,914
7,335
7,3355,9146,2133,3761,9551,0261,2891,0277981,078000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity -1,893-7,070-13,741-20,608-464-611-272-277-1360000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,243
Cost of Revenue-1,182
Gross Profit3,0613,061
 
Operating Income (+$)
Gross Profit3,061
Operating Expense-13,371
Operating Income-10,310-10,310
 
Operating Expense (+$)
Research Development7,598
Selling General Administrative4,250
Selling And Marketing Expenses1,709
Operating Expense13,37113,557
 
Net Interest Income (+$)
Interest Income851
Interest Expense-31
Other Finance Cost-31
Net Interest Income851
 
Pretax Income (+$)
Operating Income-10,310
Net Interest Income851
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,411-11,209
EBIT - interestExpense = -10,341
-9,411
-6,218
Interest Expense31
Earnings Before Interest and Taxes (EBIT)-10,310-9,380
Earnings Before Interest and Taxes (EBITDA)-9,756
 
After tax Income (+$)
Income Before Tax-9,411
Tax Provision--3,162
Net Income From Continuing Ops-6,248-6,248
Net Income-6,248
Net Income Applicable To Common Shares-6,248
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,553
Total Other Income/Expenses Net899-851
 

Technical Analysis of Orthocell
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Orthocell. The general trend of Orthocell is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Orthocell's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Orthocell Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.37 < 0.37 < 0.4.

The bearish price targets are: 0.37 > 0.322 > 0.32.

Tweet this
Orthocell Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Orthocell Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Orthocell Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Orthocell Ltd. The current macd is -0.00662225.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Orthocell price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Orthocell. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Orthocell price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Orthocell Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOrthocell Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Orthocell Ltd. The current adx is 12.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Orthocell shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Orthocell Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Orthocell Ltd. The current sar is 0.41115683.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Orthocell Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of pri